| |
| |
|
| Insider
Information: |
Johnston David Brannon |
| Relationship: |
Chief Financial Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
227,527 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,345,504 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
227,527 |
|
|
| Total
Value |
$6,345,504 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aveo Pharmaceuticals Inc |
AVEO |
Chief Financial Officer |
2013-10-02 |
46,837 |
2011-02-15 |
0 |
Premium* |
|
|
Immunogen Inc |
IMGN |
Chief Financial Officer |
2018-06-06 |
180,690 |
2015-08-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2018-06-06 |
4 |
AS |
$11.02 |
$110,200 |
D/D |
(10,000) |
180,690 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2018-06-06 |
4 |
OE |
$3.05 |
$30,500 |
D/D |
10,000 |
190,690 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2018-03-15 |
4 |
AS |
$11.53 |
$115,300 |
D/D |
(10,000) |
180,690 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2018-03-15 |
4 |
OE |
$3.05 |
$30,500 |
D/D |
10,000 |
190,690 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2018-02-21 |
4 |
AS |
$10.87 |
$228,922 |
D/D |
(21,060) |
180,690 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2016-11-02 |
4 |
B |
$1.70 |
$16,981 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2015-09-17 |
4 |
OE |
$10.79 |
$53,950 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2015-09-17 |
4 |
AS |
$15.00 |
$75,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2015-08-03 |
4 |
AS |
$17.04 |
$85,180 |
D/D |
(5,000) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Financial Officer |
• – – |
2015-08-03 |
4 |
OE |
$10.79 |
$53,950 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2013-10-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(52,200) |
46,837 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
95,943 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2013-03-14 |
4 |
S |
$7.34 |
$7,784 |
D/D |
(1,061) |
55,943 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2013-01-28 |
4 |
AS |
$7.77 |
$8,937 |
D/D |
(1,150) |
57,004 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2013-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,500 |
58,154 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2012-09-13 |
4 |
S |
$10.60 |
$14,696 |
D/D |
(1,386) |
24,593 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2012-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
19,700 |
25,154 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-12-01 |
4 |
AS |
$16.74 |
$16,737 |
D/D |
(1,000) |
6,000 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-12-01 |
4 |
OE |
$5.60 |
$5,600 |
D/D |
1,000 |
7,000 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-11-01 |
4 |
AS |
$15.44 |
$30,878 |
D/D |
(2,000) |
6,000 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-11-01 |
4 |
OE |
$5.60 |
$11,200 |
D/D |
2,000 |
8,000 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-10-03 |
4 |
OE |
$5.60 |
$11,200 |
D/D |
2,000 |
8,000 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-10-03 |
4 |
AS |
$15.43 |
$30,867 |
D/D |
(2,000) |
6,000 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-09-01 |
4 |
AS |
$16.87 |
$33,747 |
D/D |
(2,000) |
6,000 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-09-01 |
4 |
OE |
$5.60 |
$11,200 |
D/D |
2,000 |
8,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
